MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3892/or.2017.5977

Медицинская библиотека · Oncology reports · 2017

Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest.

Oura Kyoko, Tadokoro Tomoko, Fujihara Shintaro, Morishita Asahiro, Chiyo Taiga, Samukawa Eri, Yamana Yoshimi, Fujita Koji, Sakamoto Teppei, Nomura Takako, Yoneyama Hirohito, Kobara Hideki, Mori Hirohito, Iwama Hisakazu, Okano Keiichi, Suzuki Yasuyuki, Masaki Tsutomu

СтатьяПеревод в очереди

Аннотация

Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and the third leading cause of cancer-related death. Telmisartan, a widely used antihypertensive drug, is an angiotensin II type 1 (AT1) receptor blocker (ARB) that might inhibit cancer cell proliferation, but the mechanisms through which telmisartan affects various cancers remain unknown. The aim of the present study was to evaluate the effects of telmisartan on human HCC and to assess the expression of microRNAs (miRNAs). We studied the effects of telmisartan on HCC cells using the HLF, HLE, HepG2, HuH-7 and PLC/PRF/5 cell lines. In our experiments, telmisartan inhibited the proliferation of HLF, HLE and HepG2 cells, which represent poorly differentiated types of HCC cells. However, HuH-7 and PLC/PRF/5 cells, which represent well-differentiated types of HCC cells, were not sensitive to telmisartan. Telmisartan induced G0/G1 cell cycle arrest of HLF cells by inhibiting the G0-to-G1 cell cycle transition. This blockade was accompanied by a marked decrease in the levels of cyclin D1, cyclin E and other cell cycle-related proteins. Notably, the activity of the AMP-activated protein kinase (AMPK) pathway was increased, and the mammalian target of rapamycin (mTOR) pathway was inhibited by telmisartan treatment. Additionally, telmisartan increased the level of caspase-cleaved cytokeratin 18 (cCK18), partially contributed to the induction of apoptosis in HLF cells and reduced the phosphorylation of ErbB3 in HLF cells. Furthermore, miRNA expression was markedly altered by telmisartan in vitro. In conclusion, telmisartan inhibits human HCC cell proliferation by inducing cell cycle arrest.

Для цитирования: Oura Kyoko, Tadokoro Tomoko, Fujihara Shintaro, Morishita Asahiro, Chiyo Taiga, Samukawa Eri, Yamana Yoshimi, Fujita Koji, Sakamoto Teppei, Nomura Takako, Yoneyama Hirohito, Kobara Hideki, Mori Hirohito, Iwama Hisakazu, Okano Keiichi, Suzuki Yasuyuki, Masaki Tsutomu. Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest.. Oncology reports. 2017. DOI: 10.3892/or.2017.5977.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.